Spikevax is now approved for all adults aged 65 years and older, and individuals aged 6 months through 64 years at increased risk for COVID-19 disease CAMBRIDGE, MA / ACCESS Newswire / July 10, 2025 / ...

The approval comes amid regulatory upheaval under HHS head Robert F. Kennedy Jr., who has pushed for changes around mRNA ...

House Democrats on the Oversight Committee are calling for an urgent briefing with staff from the Centers for Disease Control ...

Moderna’s shares were up nearly 3% at the time of writing. The vaccine was previously available for pediatric populations ...